BioPacific Investors
Overview
BioPacific Investors is an angel investment group established to leverage cross-border opportunities in early-stage life science and healthcare sectors. The firm primarily targets U.S.-based companies that incorporate China and Asia into their business strategies. Their investment approach includes seed or Series A funding ranging from $250,000 to $1 million, aiming to support companies in their initial growth phases. The group's strategy emphasizes facilitating access to government and venture capital follow-on funding in China, providing a pathway for U.S. companies to expand into Asian markets. BioPacific Investors operates with a no-fee application process, though companies are subject to a screening process for approval. This approach underscores their commitment to fostering international collaboration and growth in the life sciences and healthcare industries. By focusing on cross-border opportunities, BioPacific Investors plays a pivotal role in bridging the gap between U.S. companies and the expansive Asian markets, particularly China. Their investments are designed to catalyze growth and innovation by connecting U.S. companies with the resources and opportunities available in Asia, thereby enhancing their global reach and impact.
Investment Focus
- U.S.-based life science and healthcare companies
- Incorporation of China/Asia into business strategy
- Seed or Series A funding stage
- Investment size between $250,000 and $1 million
- Subject to screening process approval
Portfolio Companies
Reach BioPacific Investors directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about BioPacific Investors
What sectors does BioPacific Investors invest in?
BioPacific Investors invests in Healthcare and Life Sciences, and is based in California, United States. BioPacific Investors is listed as a angel investor in the ConnectSafely investor database.
What stage does BioPacific Investors invest at?
BioPacific Investors backs companies at Seed and Series A, writing cheques of 250K - 1M.
Which regions does BioPacific Investors invest in?
BioPacific Investors invests across United States, Japan, Singapore, China, India and Indonesia.
Who are the partners at BioPacific Investors?
Team members listed for BioPacific Investors include Ann Gaddy (Co-Founder and Managing Director).
What companies has BioPacific Investors invested in?
BioPacific Investors's portfolio includes NovaScan.
How do I contact BioPacific Investors?
BioPacific Investors's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
